Do you want to read an article? Please log in or register.
Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial
Asthma
Related content
Asthma
Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial
Allergy Asthma Immunol Res
Lai K, Yan Z, Qian D, Zhang X, Bian T, Dai X, Li H, Lin L, Wang J, Wang L, Yang J, Hu Y, Li H, Nie X, Jin F, Li G, Sun S, Xu F, Zhao H, Chen Y, Liu C, Zhu H, Li J, Guo Y, Zhong N
doi: 10.4168/aair.2026.18.e1
RECOMMENDED
Lung Cancer
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Liu Y, Li D, Wu L, Li X, Fan Y, Zhang M, Guo J, Yao Y, Fang J, Tang KJ, Luo F, Yu Y, Min X, Song Z, Hu J, Ma R, Yang H, Shu Y, Xu R, Wang B, Dong X, Chen Y, Mao R, Zhang V, Fang Y
doi: 10.1016/j.cllc.2026.06.003
Asthma
Dupilumab Among Patients with Uncontrolled Severe Asthma in China: A Cost-Utility Analysis
J Asthma Allergy
Liu Z, Xu M, Zhu H, Huang J, Ye X, Shen X, Fan X
doi: 10.2147/JAA.S545324
Asthma
Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)
Allergy Asthma Immunol Res
Sohn KH, Lee SK, Lee HY, Kim SR, Lee SE, Kim JH, Song WJ, Kim SH, Korean Severe Asthma Registry (KoSAR) Investigators
doi: 10.4168/aair.2026.18.2.192
COMMENTED
Asthma
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Wechsler ME, Brightling CE, Brusselle G, Caminati M, Soler T, González EM, Nakwan N, Capala-Szczurko I, Hunter G, Almqvist G, Lal H, Kabelis P, Scrigner P, Matsunaga Y, Molfino N, Ponnarambil SS, SUNRISE study investigators
doi: 10.1016/S2213-2600(26)00076-7
Asthma
Association of Tirzepatide versus Semaglutide with Risk of Asthma Exacerbation in Patients with Asthma and Type 2 Diabetes: A US Multicenter Retrospective Cohort Study
J Asthma Allergy
Hung CT, An CY, Suk CW, Lee TW, Hung SH
doi: 10.2147/JAA.S637738
Lung Cancer
LRP1B loss predicts sensitivity to immunotherapy in patients with NSCLC: an analysis of the phase 3 Checkmate 026 randomized trial
Clin Cancer Res
Armstrong AJ, Dietz H, Balli D, Geese WJ, Duan C, Hung YH, Ip V, Li G, Graf RP, Ready N
doi: 10.1158/1078-0432.CCR-25-0952
Asthma
Efficacy and Safety of Dupilumab in Children With Moderate-to-Severe Asthma: A Systematic Review of Emerging Phase 3 Evidence
Pediatr Pulmonol
Ghadah A, Aryam A, Shahad A, Hatun A, Amani A, Zinab B, Anoud A, Abdulmajeed A, Tamer A
doi: 10.1002/ppul.71391
Asthma
Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study
J Asthma Allergy
Montoro Ferrer A, Moro Moro MDM, Parra Borreguero FM, Moreno-Ancillo A, Extremera Ortega AM, Galindo-Bonilla PA, Jiménez Lara M, Bravo Nieto JM, Jiménez Arroyo M, Lemus Calderón JA, Espinosa de Los Monteros Garde MJ
doi: 10.2147/JAA.S582686